Entity Common Stock, Shares Outstanding of Cyclo Therapeutics, Inc. from 11 Aug 2011 to 12 Nov 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Cyclo Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 Aug 2011 to 12 Nov 2024.
  • Cyclo Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2024 was 28,768,055, a 27% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Cyclo Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 28,768,055 +6,035,653 +27% 12 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 28,696,028 +9,387,579 +49% 14 Aug 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 28,715,740 +18,160,840 +172% 15 Mar 2024 10-K/A 18 Dec 2024 2024 FY
Q3 2023 22,732,402 +14,250,554 +168% 13 Nov 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 19,308,449 11 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 10,554,900 +2,149,675 +26% 31 Mar 2023 10-K/A 01 May 2023 2022 FY
Q3 2022 8,481,848 10 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q1 2022 8,405,225 +2,112,277 +34% 10 Mar 2022 10-K 11 Mar 2022 2021 FY
Q4 2021 6,455,225 15 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 6,438,172 -135,233,290 -95% 13 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 6,292,948 -115,378,514 -95% 12 Mar 2021 10-K 12 Mar 2021 2020 FY
Q3 2020 169,982,602 +48,761,140 +40% 13 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 141,671,462 +20,636,999 +17% 14 Aug 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 121,671,462 +30,406,999 +33% 15 Mar 2020 10-K 30 Mar 2020 2019 FY
Q3 2019 121,221,462 +33,476,962 +38% 14 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 121,034,463 +33,289,963 +38% 13 Aug 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 91,264,463 +17,759,963 +24% 11 Mar 2019 10-K 15 Mar 2019 2018 FY
Q3 2018 87,744,500 +14,638,666 +20% 09 Nov 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 87,744,500 +14,638,666 +20% 14 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 73,504,500 +797,139 +1.1% 10 Apr 2018 10-K 16 Apr 2018 2017 FY
Q3 2017 73,105,834 +6,153,305 +9.2% 09 Nov 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 73,105,834 +6,329,014 +9.5% 11 Aug 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 72,707,361 +13,930,541 +24% 01 Mar 2017 10-K 17 Mar 2017 2016 FY
Q3 2016 66,952,529 +8,175,709 +14% 10 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 66,776,820 +9,300,000 +16% 11 Aug 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 58,776,820 +4,214,465 +7.7% 17 Mar 2016 10-K 30 Mar 2016 2015 FY
Q3 2015 58,776,820 +4,289,465 +7.9% 09 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 57,476,820 +3,089,465 +5.7% 11 Aug 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 54,562,355 +6,000,000 +12% 25 Mar 2015 10-K 27 Mar 2015 2014 FY
Q3 2014 54,487,355 +16,925,000 +45% 10 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 54,387,355 +17,391,347 +47% 12 Aug 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 48,562,355 +11,566,347 +31% 03 Mar 2014 10-K 04 Mar 2014 2013 FY
Q3 2013 37,562,355 12 Nov 2013 10-Q 13 Nov 2013 2013 Q3
Q2 2013 36,996,008 +314,465 +0.86% 07 Aug 2013 10-Q 14 Aug 2013 2013 Q2
Q1 2013 36,996,008 +314,465 +0.86% 11 Mar 2013 10-K 14 Mar 2013 2012 FY
Q4 2012 36,681,543 30 Nov 2012 10-Q 13 Nov 2012 2012 Q3
Q2 2012 36,681,543 +1,166,248 +3.3% 13 Aug 2012 10-Q 14 Aug 2012 2012 Q2
Q1 2012 36,681,543 15 Mar 2012 10-K 16 Mar 2012 2011 FY
Q3 2011 36,015,295 10 Nov 2011 10-Q/A 23 Feb 2012 2011 Q3
Q2 2011 35,515,295 11 Aug 2011 10-Q 15 Aug 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.